Pricing Log in Create free account
Saturday 31 October 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

466.16 5.43 +1.18%
Market cap
$249.1B
P/E
28.7×
Fwd P/E
27.9×
Dividend yield
2.13%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Filings

Amgen Inc. (AMGN) P/S ratio

Alert me on P/S ratio

As of 30 October 2026, Amgen Inc. (AMGN) trades at a P/S ratio of 6.6×. Over the past ten years it has ranged from 4.1× (May 2025) to 6.6× (October 2026) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 3.6× and above the Healthcare sector median of 3.6×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 4.8× 14.42%
FY2024 4.2× (25.81%)
FY2023 5.6× 5.54%
FY2022 5.3× 8.34%
FY2021 4.9× (6.86%)
FY2020 5.3× (15.11%)
FY2019 6.2× 15.21%
FY2018 5.4× (4.31%)
FY2017 5.7× 15.47%
FY2016 4.9× (13.67%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 5.1× 0.55%
Mar 2026 5.1× 6.54%
Dec 2025 4.8× 13.52%
Sep 2025 4.2× (1.89%)
42 more quarters

Against its own ten years

Low 4.1× High 6.6×
Ten-year median 5.3×
Current reading's percentile 100

P/S ratio against peers

Company P/S ratio
BMY Bristol Myers Squibb Company compare 2.6×
PFE Pfizer Inc. compare 2.7×
NVO Novo Nordisk A/S compare 3.4×
AZN AstraZeneca PLC compare 4.7×
NVS Novartis AG compare 5.4×
MRK Merck & Co., Inc. compare 5.6×
AMGN Amgen Inc. 6.6×
GILD Gilead Sciences, Inc. compare 7.0×
ABBV AbbVie Inc. compare 8.1×
Drug Manufacturers General industry median 3.6×
Healthcare sector median 3.6×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on AMGN